Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Anti-Cancer Compound Derived from Ancient Plant

28.05.2010
UA researchers make the discovery after using a different agricultural method to grow Withania somnifera (L.) Dunal, a winter cherry plant.

University of Arizona scientists have used a new quick-growing technique to produce a water-soluble form of a plant compound that combats cancer and encourages the survival of healthy cells.

Research trials are under way on this sulfate form of withaferin A, which could develop into a new anti-cancer drug.

Scientifically studied since the 1960s, withaferin A reduces tumor mass by preventing the growth of blood vessels that make a tumor malignant. The compound is derived from the roots of a winter cherry plant, the extracts of which have been used for more than 3,000 years in India as a general tonic to build stamina, improve mental concentration, relieve stress and enhance health.

"Finding a water-soluble analog of withaferin A is significant, especially if it turns out to be a clinically useful drug," said Leslie Gunatilaka, director of the UA's Southwest Center for Natural Products Research and Commercialization, or Natural Products Center.

Withania is widely cultivated for commercial use in its native India, and also in the Middle East and in North America. It often is sold under the name ashwagandha as a dietary supplement in the U.S. and Europe.

Although traditionally grown outdoors in soil, the UA team decided to use an entirely nontraditional method - aeroponics - to produce bulk amounts of withaferin A needed for biological evaluation.

In aeroponics, plants are set over enclosed chambers where their suspended roots are misted with water and nutrients, instead of growing in soil.

The withania plants grew about five times larger using this method than if they had been grown in soil.

"Using the aeroponic system for cultivation, we were able to produce more than 20 grams of withaferin A in a single greenhouse. It normally costs around $195 for just 10 milligrams," Gunatilaka said. "Also, it usually takes two to three years to mature to sizeable roots to be commercially viable, but here it takes just six to nine months."

Not only did the aeroponic method yield bigger plants faster, with more withaferin A than usual, it also unexpectedly stimulated the plants to produce large amounts of the new natural product - a water-soluble sulfate form of withaferin A.

Upon testing, this new form demonstrated the same bioactivity as withaferin A. It was able to inhibit the proliferation and survival of tumor cells, disrupt tumor formation and induce the healthy cells' heat-shock response to reduce stress and increase survival, according to the researchers.

The difference is that the sulfate form of withaferin A is slower acting and water-soluble; it can be converted to withaferin A in cell culture media. The researchers, expecting that this withaferin A form will convert to its active form when metabolized in the body, are pursuing further testing in animal models. The patent will be held by the UA and the Massachusetts Institute of Technology.

Natural Products Center scientists collaborated with researchers from the Whitehead Institute at MIT on this project. In addition to Gunatilaka, the researchers included Ya-ming Xu, Marilyn T. Marron, Emily Seddon and Stephen P. McLaughlin of the Natural Products Center; Dennis Ray of the UA School of Plant Sciences; and Luke Whitesell of the Whitehead Institute.

The UA College of Agriculture and Life Sciences provided funding for the project, along with the USDA.

Withaferin A is just one of hundreds of such compounds that scientists with the Natural Products Center have isolated, characterized and evaluated since the center's inception in 1996. Center researchers look for compounds in desert plants and their associated microorganisms that can improve human health and be developed as potential industrial products in Arizona.

Natural Products Center scientists have discovered several other compounds in desert organisms that can significantly inhibit the growth of tumors. Many have been patented and have progressed to extended evaluation for their pharmaceutical value.

As part of the Office of Arid Lands Studies, the Natural Products Center recently joined the School of Natural Resources and the Environment in the UA's College of Agriculture and Life Sciences.

CONTACTS:

Leslie Gunatilaka, Natural Products Center (520-621-9932; leslieg@ag.arizona.edu)

Susan McGinley, College of Agriculture and Life Sciences (520-621-7182; mcginley@ag.arizona.edu)

Jennifer Fitzenberger | University of Arizona
Further information:
http://www.arizona.edu

More articles from Life Sciences:

nachricht Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>